Perrigo Co PLC (PRGO)

69.24
1.30 1.90
NYSE : Health Care
Prev Close 67.96
Open 66.86
Day Low/High 66.86 / 69.47
52 Wk Low/High 67.08 / 133.53
Volume 1.24M
Avg Volume 2.04M
Exchange NYSE
Shares Outstanding 143.37M
Market Cap 9.77B
P/E Ratio N/A
Div & Yield 0.64 (0.90%)

Latest News

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

The Street took a look at the top 15 activist hedge funds and their director-election records over the past six years

Perrigo Provides Update On 2016 Form 10-K Filing

Perrigo Provides Update On 2016 Form 10-K Filing

- Continues to work with independent auditor, and expects to file its Form 10-K as soon as practical

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.

Mylan's Governance May Be the Root of Its Problems

Mylan's Governance May Be the Root of Its Problems

The scandals plaguing the pharmaceutical company can be traced to lack of change at the board level.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Perrigo Company Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Perrigo Company Plc

Levi & Korsinsky announces it has commenced an investigation of Perrigo Company plc (NYSE:PRGO).

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Perrigo Company Plc - PRGO

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Perrigo Company Plc - PRGO

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Perrigo Company plc (NYSE:PRGO) resulting from allegations that Perrigo may have...

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

Perrigo also said it will review its API business, which provides differentiated active pharmaceutical ingredients and finished dosage forms for the branded and generic industries.

Perrigo Announces Leadership Changes

Perrigo Announces Leadership Changes

Appoints Ron Winowiecki as Acting CFO Following Resignation of Judy L. Brown

How Starboard Hopes to Extract Value From Tribune

How Starboard Hopes to Extract Value From Tribune

The fund recently disclosed a stake in the broadcaster, an investment suggesting a campaign pushing for stock buybacks, asset sales or an auction of the whole company could be next.

Why Big Activist Is Targeting Tribune Media

Why Big Activist Is Targeting Tribune Media

Starboard Value recently disclosed a stake in the broadcaster, an investment suggesting a campaign pushing for stock buybacks, asset sales or an auction of the whole company could be next.

Bristol-Myers Buys Back Shares, Shuffles Board

Bristol-Myers Buys Back Shares, Shuffles Board

The drug company will carry out 80% of a $2B repurchase by Feb. 28 after pressure from insurgent Jana Partners. Icahn also reportedly acquired a stake, with focus on M&A.

Perrigo Company Becomes #241 Most Shorted S&P 500 Component, Replacing Baxter International

Perrigo Company Becomes #241 Most Shorted S&P 500 Component, Replacing Baxter International

The most recent short interest data has been released for the 01/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks

With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks

The activist investor landed board seats on two critical strategic review groups, suggesting that a sale of two non-core business units could happen soon.

Board Revised as Perrigo Settles With Activist Investor Starboard

Board Revised as Perrigo Settles With Activist Investor Starboard

Starboard CEO Jeff Smith and two others are joining the board. The activist investor will also recommend two additional directors.

Perrigo Announces Agreement With Starboard

Perrigo Announces Agreement With Starboard

Company to Reconstitute Board with Five New Independent Directors

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.

Jump on Harley Davidson, but Stay Away From Costamare: 'Mad Money' Lightning Round

Jump on Harley Davidson, but Stay Away From Costamare: 'Mad Money' Lightning Round

Jim Cramer likes Harley and Enterprise Products Partners, but says stay away from Costamare and Achaogen.

Earnings, Not Just the Trump Rally, Drive Stocks: Cramer's 'Mad Money' Recap (Wednesday 1/18/17)

Earnings, Not Just the Trump Rally, Drive Stocks: Cramer's 'Mad Money' Recap (Wednesday 1/18/17)

Jim Cramer explains how bullish comments from one semiconductor equipment maker lifts shares throughout the sector.